Newsroom | 45718 results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. “John is a proven global finance executive with extensive operational expertise and a successful track record leading complex transformation initiatives,” said Hider. “He is an ideal fit for...

RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene (intismeran; V940 or mRNA-4157), a novel investigational mRNA-based individualized neoantigen therapy (INT) being jointly developed by Merck and Moderna, in combination with KEYTRUDA® (pembrolizumab), Merck’s a...

بالو ألتو، كاليفورنيا--(BUSINESS WIRE)--تعد GenBio AI ‏(يشار إليها باسم "GenBio") شركة ذكاء اصطناعي للعلوم شارك في تأسيسها David Baker، الحائز على جائزة نوبل، وعالم الذكاء الاصطناعي الرائد Eric Xing، وغيرهما من الباحثين البارزين في علوم الحياة والذكاء الاصطناعي من جامعة ستانفورد، وجامعة كارنيجي ميلون، وجامعة محمد بن زايد للذكاء الاصطناعي، وجامعة هارفارد، ومعهد وايزمان، ومؤسسات بحثية أخرى. ولقد أعلنت الشركة اليوم عن إطلاق AIDO Cell، وهو نموذج عالم افتراضي للخلية، وهو أول نظام قادر على محاكاة الخل...

EDMONTON, AB--(BUSINESS WIRE)--CUPE Alberta President Raj Uppal is calling out the Liberal government in Ottawa for its inaction while the UCP dramatically expands private, patient paid health care in the province. “It’s been almost a year since the UCP passed Bill 11, allowing wealthy patients to buy their way to the front of the line for health care services,” said Uppal. “After all that time, Minister Michel this week sent a sternly worded note to the province asking them to change direction...

PALO ALTO, California--(BUSINESS WIRE)--GenBio AI ("GenBio") è una società specializzata in IA per uso scientifico, cofondata dal premio Nobel David Baker, dallo scienziato leader in ambito IA Eric Xing e da altri importanti ricercatori nei settori di scienze della vita e IA provenienti da Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, Weizmann Institute e da altri istituti di ricerca. Oggi l'azienda ha presentato AIDO Cell, il suo modell...

PALO ALTO, Calif.--(BUSINESS WIRE)--GenBio AI ('GenBio') is een 'AI for Science'-bedrijf dat mede is opgericht door Nobelprijswinnaar David Baker, vooraanstaand AI-wetenschapper Eric Xing en andere prominente onderzoekers op het gebied van levenswetenschappen en kunstmatige intelligentie. Zij zijn afkomstig van instellingen als Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, het Weizmann Institute en andere onderzoeksinstellingen. Vandaag...

PALO ALTO, Kalifornien--(BUSINESS WIRE)--GenBio AI („GenBio“) ist ein Unternehmen, das KI für die Wissenschaft einsetzt und von Nobelpreisträger David Baker, dem führenden KI-Wissenschaftler Eric Xing und anderen prominenten Forschern aus den Bereichen Life Science und künstliche Intelligenz von Stanford, der Carnegie Mellon University, der Mohamed Bin Zayed University of Artificial Intelligence, Harvard, dem Weizmann-Institut und anderen Forschungsinstituten gegründet wurde. Heute stellte das...

PALO ALTO, Californie--(BUSINESS WIRE)--GenBio AI (« GenBio ») est une entreprise spécialisée dans l’intelligence artificielle au service de la science. Elle a été cofondée par le lauréat du prix Nobel David Baker, le scientifique de renom et spécialiste de l’IA Eric Xing, ainsi que par d’autres chercheurs éminents dans les domaines des sciences de la vie et de l’IA, issus de Stanford, de la Mohamed Bin Zayed University of Artificial Intelligence, de Harvard, de l’Institut Weizmann des sciences...

PALO ALTO, California--(BUSINESS WIRE)--GenBio AI («GenBio») es una empresa dedicada a la IA aplicada a la ciencia, cofundada por el premio Nobel David Baker, el destacado científico en IA Eric Xing y otros destacados investigadores en ciencias de la vida e inteligencia artificial procedentes de Stanford, Carnegie Mellon, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, Weizmann Institute y otras instituciones de investigación. Hoy, la empresa ha presentado AIDO Cell, su modelo...

HOUSTON--(BUSINESS WIRE)--Prodigy Care Services, a pharmacist-founded workers' compensation pharmacy company, today announced its debut on the 2026 Inc. 5000 following three-year revenue growth of 975%. Prodigy ranks No. 43 among Health Services companies, No. 47 among Texas companies and No. 354 nationwide, placing the company within the top 7% of America's fastest-growing private companies. Founded in 2020, Prodigy manages pharmacy spend for workers' compensation payers under clinical oversig...